How Many People Take Wegovy and Why It’s Surging in Popularity

Introduction

The rise of GLP-1 medications has moved from clinical circles to kitchen-table conversations across the country. If you have noticed more headlines about weight loss injections recently, you are not alone. Millions of Americans are currently navigating the complexities of modern weight management, often after years of frustration with traditional diets that failed to produce lasting results. At TrimRx, we understand that the decision to explore medical weight loss is deeply personal and often driven by a desire for better long-term health. This article examines the data behind the growth of Wegovy® and other semaglutide-based treatments. We will explore exactly how many people take Wegovy, why the demand has reached record levels, and what these trends mean for the future of metabolic health. Our goal is to provide you with the facts needed to understand this evolving landscape.

For readers who are exploring online access and personalized care, our guide to how to get a GLP-1 prescription online provides additional context about the assessment and consultation process.

Quick Answer: Recent data suggests that approximately 16 million American adults have used a GLP-1 medication like Wegovy®. As of mid-2024, approximately 25,000 new patients are starting Wegovy every week, highlighting a massive shift in how obesity and metabolic health are treated in the United States.

The Rising Number of Wegovy Users in the United States

Recent surveys and pharmaceutical reports provide a clear picture of just how quickly the landscape is shifting. According to a Gallup poll and research from the KFF, between 6% and 12% of American adults have tried an injectable weight loss medication. This represents a significant portion of the population, specifically those struggling with obesity or weight-related health conditions.

In February 2024 alone, Wegovy accounted for approximately 28% of all prescriptions written for weight loss medications. This specific brand has become the most searched and one of the most widely used options in its class. To put the growth in perspective, the manufacturer reported that by May 2024, the number of people starting the medication each week had increased fivefold compared to the previous December.

The sheer volume of users has at times outpaced the supply chain. During the peak of the recent shortage, hundreds of thousands of people were seeking the medication simultaneously. This high demand is reflective of a broader trend: a move away from the “willpower” myth of weight loss and toward a biological understanding of metabolic health.

Understanding the 16 Million Milestone

The figure of 16 million users includes a range of medications within the GLP-1 (glucagon-like peptide-1) category. This group of drugs includes Wegovy, Ozempic®, and Zepbound®. While some of these are specifically approved for Type 2 diabetes, a large number of patients use them off-label for weight management under the guidance of healthcare providers.

The adoption rate is particularly high among adults aged 40 to 59. This demographic often faces the most significant challenges with metabolic slowing and weight-related comorbidities. As more people share their experiences, the stigma surrounding medical intervention for weight loss continues to diminish, leading to even higher adoption rates.

Why Wegovy Became a Household Name

The popularity of Wegovy is not merely a result of marketing. It is driven by significant clinical outcomes that have changed the expectations for what a weight loss program can achieve. Wegovy contains semaglutide, a molecule that mimics a hormone naturally produced in the gut.

For a broader explanation of how these medications influence appetite, digestion, and satiety, see our guide to what GLP-1 medications are and how they work.

This hormone, GLP-1, plays several critical roles in the body:

• Appetite Regulation: It signals the brain to feel satisfied with smaller portions of food.
• Gastric Emptying: It slows the rate at which food leaves the stomach, helping you feel full for longer periods.
• Insulin Support: It helps the body manage blood sugar levels more effectively after eating.

Clinical Efficacy and Weight Loss Results In large-scale clinical trials, participants using semaglutide alongside lifestyle changes lost an average of 12% to 15% of their initial body weight over 68 weeks. For an individual weighing 250 pounds, this can represent a loss of 30 to 37 pounds. Compared to older generations of weight loss drugs, which often produced only modest results or carried significant cardiac risks, this level of efficacy is a primary driver for the current surge in users.

Key Takeaway: The popularity of Wegovy stems from its ability to address the biological roots of hunger and satiety, rather than relying solely on calorie restriction. This shift allows many individuals to achieve weight loss milestones that were previously unreachable.

Beyond Weight Loss: The Heart Health Connection

A major factor in the continued growth of Wegovy usage is its expanded clinical application. In 2024, the FDA approved a new indication for Wegovy: reducing the risk of major cardiovascular events. This includes heart attacks, strokes, and cardiovascular-related deaths in adults with established heart disease who also have obesity or are overweight.

The SELECT Trial Findings The approval was based on the SELECT trial, a massive study involving over 17,000 participants. The research demonstrated that patients taking Wegovy had a 20% lower risk of experiencing a major adverse cardiac event compared to those taking a placebo.

This finding changed the conversation from “cosmetic” weight loss to essential “preventative” medicine. Cardiologists are now increasingly prescribing these medications not just for the scale, but to protect the heart. Experts estimate that as many as 6.6 million Americans meet the specific criteria for this cardioprotective use, which may further increase the number of people taking the drug in the coming years.

Who Is Eligible for Wegovy?

While the demand is high, these medications are intended for specific patient profiles. Medical providers generally follow established clinical guidelines to determine eligibility. Typically, a patient may be considered a candidate for Wegovy if they meet one of the following criteria:

1. A Body Mass Index (BMI) of 30 or higher (classified as obesity).
2. A BMI of 27 or higher (classified as overweight) along with at least one weight-related health condition.

Weight-related conditions often include high blood pressure (hypertension), Type 2 diabetes, or high cholesterol. At TrimRx, we believe that eligibility should always be determined through a personalized medical assessment. This ensures that the medication is safe and appropriate for your unique health history and goals.

If you want to find out whether a prescription weight loss program may fit your health profile, you can complete a free eligibility assessment.

Bottom line: Wegovy is a prescription medication designed for those with significant weight-related health risks, and its use should always be supervised by a licensed healthcare professional to monitor for safety and efficacy.

The Challenge of Long-Term Adherence

Despite the high number of people starting Wegovy, staying on the medication long-term presents challenges. Data from pharmacy claims analyses suggest that a significant number of patients discontinue treatment within the first year or two.

Why Do People Stop? There are several common reasons for the drop-off in usage:

• Side Effects: Nausea, vomiting, and diarrhea are common, especially during the initial “titration” phase when the dose is gradually increased.
• Supply Issues: Nationwide shortages have made it difficult for some patients to fill their prescriptions consistently.
• Insurance Barriers: Not all insurance plans cover weight loss medications, and some require complex “prior authorization” processes.
• Plateaus: Some patients stop the medication once they reach a weight goal, although clinical evidence suggests that obesity is a chronic condition that may require long-term management to prevent weight regain.

Research indicates that only about 24% of patients prescribed Wegovy are still taking it two years later. This highlights the importance of a comprehensive support system. Sustainable weight loss is rarely achieved through medication alone; it requires a combination of clinical oversight, nutritional guidance, and realistic lifestyle adjustments.

The Role of Compounded Medications During Shortages

The intense demand for semaglutide led the FDA to list the drug in a state of shortage for an extended period. During such shortages, federal law allows for the preparation of compounded medications. This has led to a rise in the use of compounded semaglutide and compounded tirzepatide.

It is important to understand the distinction:

Myth: Compounded semaglutide is the same as the branded version and is FDA-approved. Fact: Compounded medications are not FDA-approved. However, they can be prepared by FDA-registered, inspected compounding pharmacies to help meet patient needs when branded versions are unavailable.

We focus on connecting patients with licensed providers who can navigate these options. By using highly regulated, FDA-registered pharmacies, patients can access personalized dosages and maintain their treatment progress even when branded supplies are constrained. Our platform ensures that every step of this process is medically supervised.

How Telehealth is Improving Access

The traditional path to obtaining weight loss medication often involved long wait times for specialist appointments and uncomfortable conversations in crowded waiting rooms. Telehealth has fundamentally changed this experience, contributing to the high number of people now able to access care.

For more information about the online assessment, provider review, and follow-up process, read our guide to accessing GLP-1 medications through telehealth.

Telehealth-first platforms allow individuals to:

• Complete health assessments from the privacy of their own homes.
• Consult with specialists who understand the nuances of GLP-1 therapy.
• Receive personalized treatment plans without geographical barriers.
• Access ongoing support for managing side effects and adjusting dosages.

Our model at TrimRx is built on this telehealth-first approach. We remove the traditional barriers to care, providing a seamless path from the initial assessment to the delivery of medication. This personalized approach is designed to help patients not just start their journey, but stay on it.

What to Expect When Starting a Program

If you are considering joining the millions of people using GLP-1 medications, it is helpful to know what the onboarding process looks like. Most successful programs follow a structured path to ensure safety.

Step 1: Complete an Assessment The process begins with a detailed health history and a weight loss assessment quiz. This helps providers determine if you meet the clinical criteria for treatment.

Step 2: Provider Consultation A licensed healthcare professional reviews your profile. They may request lab work to check your metabolic markers, such as your A1C or lipid levels, before confirming your eligibility.

Step 3: Personalized Treatment Plan If approved, you receive a prescription tailored to your needs. This includes a “titration” schedule, starting with a low dose to allow your body to adjust and minimizing the risk of gastrointestinal side effects.

Step 4: Ongoing Monitoring and Support Regular check-ins ensure the medication is working and that any side effects are managed. This is also the time to integrate healthy habits like increased protein intake and regular physical activity to preserve muscle mass during weight loss.

When you are ready to begin, you can take the free assessment quiz to start the evaluation process.

Managing Common Side Effects

As more people take Wegovy, the collective understanding of how to manage its side effects has grown. Because semaglutide affects the digestive system, most issues are related to how the body processes food.

For additional background, our overview of common GLP-1 side effects and treatment considerations discusses the digestive symptoms that many patients encounter.

Practical Management Tips:

• Eat Smaller Meals: Since the medication slows digestion, eating large portions can lead to discomfort or nausea.
• Stay Hydrated: Drinking plenty of water is essential, especially if you experience gastrointestinal upset.
• Prioritize Protein: Maintaining muscle mass is a key part of healthy weight loss. We often suggest focusing on high-quality protein sources at every meal.
• Communicate with Your Team: If side effects feel unmanageable, your provider can often adjust your dose or offer guidance on timing and diet to help you feel better.

We also offer supplemental support through products like GLP-1 Daily Support, which can be integrated into a routine to help maintain nutrient levels and support overall wellness while on the medication.

The Future of Weight Management

The data is clear: the number of people taking Wegovy and similar medications is likely to keep growing. As clinical research continues to uncover new benefits—from kidney health to potential neurological protections—the role of GLP-1s in modern medicine will only expand.

However, the medication is just one piece of the puzzle. The most successful outcomes occur when clinical intervention is paired with empathy, education, and a long-term commitment to health. We are dedicated to providing a platform where science and support meet, ensuring that every individual has the tools they need to reclaim their metabolic health.

Conclusion

The fact that over 16 million Americans have turned to GLP-1 medications like Wegovy® underscores a major shift in our health culture. We are moving toward a future where obesity is treated as the complex biological condition it is, rather than a personal failing. At TrimRx, our mission is to help you navigate this transition with a program that is as unique as your own health profile. By combining the expertise of licensed providers with the convenience of telehealth, we make sustainable weight loss more accessible than ever before. If you are ready to see if you qualify for a personalized program, the first step is simple and can be completed entirely online.

Key Takeaway: While millions are now using these medications, the most successful journeys are those supported by a dedicated clinical team and a personalized plan tailored to the individual’s needs.

Are you ready to take the next step in your health journey?

Next Steps:

• Take our free assessment quiz to see if you qualify for a personalized prescription program.
• Explore our quick-access supplements like Weight Loss Boost for immediate support.

FAQ

How many people are currently taking Wegovy in the U.S.?

While exact real-time numbers fluctuate, reports indicate that approximately 25,000 new patients start Wegovy® every week. This contributes to the estimated 16 million Americans who have used a GLP-1 medication for weight loss or diabetes management.

Is Wegovy better than other weight loss medications?

Wegovy® (semaglutide) has shown high efficacy in clinical trials, with many patients losing 12% to 15% of their body weight. Whether it is “better” depends on your individual health history, as other options like tirzepatide may offer different results or side-effect profiles. Our comparison of semaglutide and tirzepatide treatment options offers additional educational context.

Why was there a shortage of Wegovy?

The shortage was caused by an unprecedented surge in demand that exceeded the manufacturer’s production capacity. This led many patients to seek alternative options, such as compounded semaglutide, through telehealth platforms and licensed compounding pharmacies.

Can I get Wegovy without seeing a doctor in person?

Yes, you can be evaluated for a Wegovy® prescription through a telehealth platform that connects you with licensed healthcare providers. These providers use online assessments and medical history reviews to determine eligibility and provide ongoing clinical supervision. You can see if you qualify for a personalized program.

Disclaimer: This content is for informational purposes only and does not constitute medical advice. It is not intended to diagnose, treat, cure, or prevent any disease or condition. Individual results may vary. Always consult a qualified healthcare professional before starting any weight loss program or medication.